Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 1/2016

01.01.2016 | Original Paper

Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study

verfasst von: Nanna Gilliam Toftdahl, Merete Nordentoft, Carsten Hjorthøj

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The present study established the national prevalence of substance use disorders (SUDs) among Danish psychiatric patients. Furthermore, patients with SUDs and those without SUDs were compared on a range of socio-demographic, clinical, and treatment characteristics.

Methods

Data were obtained from several Danish population-based registers. The study population was defined as all individuals with incidents of schizophrenia, schizotypal disorder, other psychoses, bipolar disorder, depression, anxiety, obsessive–compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and personality disorders since 1969. The prevalence of SUDs was examined for the following psychoactive substances: alcohol, opioids, cannabis, sedatives, cocaine, psycho-stimulants and hallucinogens.

Results

A total of 463,003 patients were included in the analysis. The prevalence of any lifetime SUD was: 37 % for schizophrenia, 35 % for schizotypal disorder, 28 % for other psychoses, 32 % for bipolar disorder, 25 % for depression, 25 % for anxiety, 11 % for OCD, 17% for PTSD, and 46 % for personality disorders. Alcohol use disorder was the most dominating SUD in every psychiatric category (25 % of all included patients). Patients with SUDs were more often men, had fewer years of formal education, more often received disability pension and died due to unnatural causes.

Conclusions

The study was the most comprehensive of its kind so far to estimate the prevalence of SUDs in an unselected population-based cohort, and it revealed remarkably high prevalence among the psychiatric patients. The results should encourage continuous focus on possible comorbidity of psychiatric patients, as well as specialised and integrated treatment along with increased support of patients with comorbid disorders.
Literatur
1.
Zurück zum Zitat Wittchen HU et al (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(9):655–679CrossRefPubMed Wittchen HU et al (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(9):655–679CrossRefPubMed
2.
Zurück zum Zitat Kessler RC et al (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6):617–627PubMedCentralCrossRefPubMed Kessler RC et al (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6):617–627PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Grant BF (1996) Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the national longitudinal alcohol epidemiologic survey. J Subst Abuse 8(2):195–210CrossRefPubMed Grant BF (1996) Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the national longitudinal alcohol epidemiologic survey. J Subst Abuse 8(2):195–210CrossRefPubMed
4.
Zurück zum Zitat Saraceno B (2002) The WHO world health report 2001 on mental health. Epidemiologia e Psichiatria Sociale 11(2):83–87CrossRefPubMed Saraceno B (2002) The WHO world health report 2001 on mental health. Epidemiologia e Psichiatria Sociale 11(2):83–87CrossRefPubMed
6.
Zurück zum Zitat Regier DA et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) Study. JAMA 264(19):2511–2518CrossRefPubMed Regier DA et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) Study. JAMA 264(19):2511–2518CrossRefPubMed
7.
Zurück zum Zitat Grant BF et al (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61(8):807–816CrossRefPubMed Grant BF et al (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61(8):807–816CrossRefPubMed
9.
Zurück zum Zitat Jimenez-Castro L et al (2010) Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry. Schizophr Res 120(1–3):87–94PubMedCentralCrossRefPubMed Jimenez-Castro L et al (2010) Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry. Schizophr Res 120(1–3):87–94PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Kessler RC et al (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch Gen Psychiatry 54(4):313–321CrossRefPubMed Kessler RC et al (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch Gen Psychiatry 54(4):313–321CrossRefPubMed
11.
Zurück zum Zitat Moore E et al (2012) The impact of alcohol and illicit drugs on people with psychosis: the second Australian national survey of psychosis. Aust N Z J Psychiatry 46(9):864–878CrossRefPubMed Moore E et al (2012) The impact of alcohol and illicit drugs on people with psychosis: the second Australian national survey of psychosis. Aust N Z J Psychiatry 46(9):864–878CrossRefPubMed
12.
Zurück zum Zitat Nesvåg R et al (2015) Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. Soc Psychiatry Psychiatr Epidemiol 50(8):1267–1276CrossRefPubMed Nesvåg R et al (2015) Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. Soc Psychiatry Psychiatr Epidemiol 50(8):1267–1276CrossRefPubMed
13.
Zurück zum Zitat Whiteford HA et al (2013) Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 382(9904):1575–1586CrossRefPubMed Whiteford HA et al (2013) Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 382(9904):1575–1586CrossRefPubMed
14.
Zurück zum Zitat Druss BG et al (2011) Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care 49(6):599–604CrossRefPubMed Druss BG et al (2011) Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care 49(6):599–604CrossRefPubMed
15.
Zurück zum Zitat Nordentoft M et al (2013) Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 8(1):e55176PubMedCentralCrossRefPubMed Nordentoft M et al (2013) Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 8(1):e55176PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Drake RE, Brunette MF (1998) Complications of severe mental illness related to alcohol and drug use disorders. Recent Dev Alcohol 14:285–299PubMed Drake RE, Brunette MF (1998) Complications of severe mental illness related to alcohol and drug use disorders. Recent Dev Alcohol 14:285–299PubMed
18.
Zurück zum Zitat Zammit S et al (2008) Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 193(5):357–363CrossRefPubMed Zammit S et al (2008) Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 193(5):357–363CrossRefPubMed
19.
Zurück zum Zitat Soyka M (2000) Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry 176:345–350CrossRefPubMed Soyka M (2000) Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry 176:345–350CrossRefPubMed
20.
Zurück zum Zitat Drake RE et al (2004) A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J 27(4):360–374CrossRefPubMed Drake RE et al (2004) A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J 27(4):360–374CrossRefPubMed
21.
Zurück zum Zitat Moore TH et al (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319–328CrossRefPubMed Moore TH et al (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319–328CrossRefPubMed
22.
Zurück zum Zitat Macleod J et al (2004) Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 363(9421):1579–1588CrossRefPubMed Macleod J et al (2004) Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 363(9421):1579–1588CrossRefPubMed
23.
Zurück zum Zitat Mueser KT, Drake RE, Wallach MA (1998) Dual diagnosis: a review of etiological theories. Addict Behav 23(6):717–734CrossRefPubMed Mueser KT, Drake RE, Wallach MA (1998) Dual diagnosis: a review of etiological theories. Addict Behav 23(6):717–734CrossRefPubMed
24.
Zurück zum Zitat Miles H et al (2003) Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatr Serv 54(4):554–561CrossRefPubMed Miles H et al (2003) Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatr Serv 54(4):554–561CrossRefPubMed
25.
Zurück zum Zitat Lai HM, Huang QR (2009) Comorbidity of mental disorders and alcohol- and drug-use disorders: analysis of New South Wales inpatient data. Drug Alcohol Rev 28(3):235–242CrossRefPubMed Lai HM, Huang QR (2009) Comorbidity of mental disorders and alcohol- and drug-use disorders: analysis of New South Wales inpatient data. Drug Alcohol Rev 28(3):235–242CrossRefPubMed
26.
Zurück zum Zitat Pedersen CB (2011) The danish civil registration system. Scand J Public Health 39(7 Suppl):22–25CrossRefPubMed Pedersen CB (2011) The danish civil registration system. Scand J Public Health 39(7 Suppl):22–25CrossRefPubMed
27.
Zurück zum Zitat Mors O, Perto GP, Mortensen PB (2011) The Danish psychiatric central research register. Scand J Public Health 39(7 Suppl):54–57CrossRefPubMed Mors O, Perto GP, Mortensen PB (2011) The Danish psychiatric central research register. Scand J Public Health 39(7 Suppl):54–57CrossRefPubMed
29.
Zurück zum Zitat Lynge E, Sandegaard JL, Rebolj M (2011) The Danish national patient register. Scand J Public Health 39(7 Suppl):30–33CrossRefPubMed Lynge E, Sandegaard JL, Rebolj M (2011) The Danish national patient register. Scand J Public Health 39(7 Suppl):30–33CrossRefPubMed
31.
Zurück zum Zitat Kildemoes HW, Sorensen HT, Hallas J (2011) The Danish national prescription registry. Scand J Public Health 39(7 Suppl):38–41CrossRefPubMed Kildemoes HW, Sorensen HT, Hallas J (2011) The Danish national prescription registry. Scand J Public Health 39(7 Suppl):38–41CrossRefPubMed
32.
Zurück zum Zitat Thygesen LC et al (2011) Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 39(7 Suppl):12–16CrossRefPubMed Thygesen LC et al (2011) Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 39(7 Suppl):12–16CrossRefPubMed
33.
Zurück zum Zitat Helweg-Larsen K (2011) The Danish register of causes of death. Scand J Public Health 39(7 Suppl):26–29CrossRefPubMed Helweg-Larsen K (2011) The Danish register of causes of death. Scand J Public Health 39(7 Suppl):26–29CrossRefPubMed
34.
Zurück zum Zitat Kavanagh DJ et al (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 66(2–3):115–124CrossRefPubMed Kavanagh DJ et al (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 66(2–3):115–124CrossRefPubMed
35.
Zurück zum Zitat Swendsen J et al (2010) Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the national comorbidity survey. Addiction 105(6):1117–1128PubMedCentralCrossRefPubMed Swendsen J et al (2010) Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the national comorbidity survey. Addiction 105(6):1117–1128PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Hansen SS et al (2000) Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 102(6):432–438CrossRefPubMed Hansen SS et al (2000) Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 102(6):432–438CrossRefPubMed
37.
Zurück zum Zitat Drake RE et al (2002) Psychosocial aspects of substance abuse by clients with severe mental illness. J Nerv Ment Disease 190(2):100–106CrossRef Drake RE et al (2002) Psychosocial aspects of substance abuse by clients with severe mental illness. J Nerv Ment Disease 190(2):100–106CrossRef
38.
Zurück zum Zitat Lembke A (2012) Time to abandon the self-medication hypothesis in patients with psychiatric disorders. Am J Drug Alcohol Abuse 38(6):524–529CrossRefPubMed Lembke A (2012) Time to abandon the self-medication hypothesis in patients with psychiatric disorders. Am J Drug Alcohol Abuse 38(6):524–529CrossRefPubMed
39.
Zurück zum Zitat Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 142(11):1259–1264CrossRefPubMed Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 142(11):1259–1264CrossRefPubMed
40.
Zurück zum Zitat Henwood B, Padgett DK (2007) Reevaluating the self-medication hypothesis among the dually diagnosed. Am J Addict 16(3):160–165CrossRefPubMed Henwood B, Padgett DK (2007) Reevaluating the self-medication hypothesis among the dually diagnosed. Am J Addict 16(3):160–165CrossRefPubMed
41.
Zurück zum Zitat Dixon L et al (1990) Acute effects of drug abuse in schizophrenic patients: clinical observations and patients’ self-reports. Schizophr Bull 16(1):69–79CrossRefPubMed Dixon L et al (1990) Acute effects of drug abuse in schizophrenic patients: clinical observations and patients’ self-reports. Schizophr Bull 16(1):69–79CrossRefPubMed
42.
Zurück zum Zitat Hvidtfeldt UA et al (2008) Alkoholforbrug i Danmark; Kvantificering og karakteristik af storforbrugere og afhængige. The National Institute of Public Health, University of Southern Denmark, Copenhagen Hvidtfeldt UA et al (2008) Alkoholforbrug i Danmark; Kvantificering og karakteristik af storforbrugere og afhængige. The National Institute of Public Health, University of Southern Denmark, Copenhagen
44.
Zurück zum Zitat Menezes PR et al (1996) Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 168(5):612–619CrossRefPubMed Menezes PR et al (1996) Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 168(5):612–619CrossRefPubMed
45.
Zurück zum Zitat Haywood TW et al (1995) Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 152(6):856–861CrossRefPubMed Haywood TW et al (1995) Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 152(6):856–861CrossRefPubMed
46.
Zurück zum Zitat Lybrand J, Caroff S (2009) Management of schizophrenia with substance use disorders. Psychiatr Clin North Am 32(4):821–833CrossRefPubMed Lybrand J, Caroff S (2009) Management of schizophrenia with substance use disorders. Psychiatr Clin North Am 32(4):821–833CrossRefPubMed
47.
Zurück zum Zitat Drake RE, Mueser KT (2000) Psychosocial approaches to dual diagnosis. Schizophr Bull 26(1):105–118CrossRefPubMed Drake RE, Mueser KT (2000) Psychosocial approaches to dual diagnosis. Schizophr Bull 26(1):105–118CrossRefPubMed
48.
Zurück zum Zitat Ridgely MS, Goldman HH, Willenbring M (1990) Barriers to the care of persons with dual diagnoses: organizational and financing issues. Schizophr Bull 16(1):123–132CrossRefPubMed Ridgely MS, Goldman HH, Willenbring M (1990) Barriers to the care of persons with dual diagnoses: organizational and financing issues. Schizophr Bull 16(1):123–132CrossRefPubMed
49.
Zurück zum Zitat Curran GM et al (2008) The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC Emerg Med 8:17PubMedCentralCrossRefPubMed Curran GM et al (2008) The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC Emerg Med 8:17PubMedCentralCrossRefPubMed
50.
Zurück zum Zitat Minassian A, Vilke GM, Wilson MP (2013) Frequent emergency department visits are more prevalent in psychiatric, alcohol abuse, and dual diagnosis conditions than in chronic viral illnesses such as hepatitis and human immunodeficiency virus. J Emerg Med 45(4):520–525CrossRefPubMed Minassian A, Vilke GM, Wilson MP (2013) Frequent emergency department visits are more prevalent in psychiatric, alcohol abuse, and dual diagnosis conditions than in chronic viral illnesses such as hepatitis and human immunodeficiency virus. J Emerg Med 45(4):520–525CrossRefPubMed
51.
Zurück zum Zitat Drake RE, Osher FC, Wallach MA (1991) Homelessness and dual diagnosis. Am Psychol 46(11):1149–1158CrossRefPubMed Drake RE, Osher FC, Wallach MA (1991) Homelessness and dual diagnosis. Am Psychol 46(11):1149–1158CrossRefPubMed
52.
Zurück zum Zitat Laursen TM et al (2007) Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 68(6):899–907CrossRefPubMed Laursen TM et al (2007) Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 68(6):899–907CrossRefPubMed
53.
Zurück zum Zitat Buckley PF (2006) Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. J Clin Psychiatry 67(Suppl 7):5–9PubMed Buckley PF (2006) Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. J Clin Psychiatry 67(Suppl 7):5–9PubMed
Metadaten
Titel
Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study
verfasst von
Nanna Gilliam Toftdahl
Merete Nordentoft
Carsten Hjorthøj
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 1/2016
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-015-1104-4

Weitere Artikel der Ausgabe 1/2016

Social Psychiatry and Psychiatric Epidemiology 1/2016 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.